Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
20.02
+0.33 (1.68%)
At close: Feb 21, 2025, 4:00 PM
20.30
+0.28 (1.40%)
After-hours: Feb 21, 2025, 5:33 PM EST
KNSA Employees
Kiniksa Pharmaceuticals International, had 297 employees as of December 31, 2023. The number of employees increased by 77 or 35.00% compared to the previous year.
Employees
297
Change (1Y)
77
Growth (1Y)
35.00%
Revenue / Employee
$1,293,259
Profits / Employee
-$30,532
Market Cap
1.45B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
KNSA News
- 1 day ago - Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025 - GlobeNewsWire
- 5 weeks ago - Kiniksa Pharmaceuticals Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance - GlobeNewsWire
- 6 weeks ago - Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference - GlobeNewsWire
- 3 months ago - Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference - GlobeNewsWire
- 4 months ago - Kiniksa Pharmaceuticals International, plc (KNSA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Kiniksa Pharmaceuticals Reports Third Quarter 2024 Financial Results and Recent Portfolio Execution - GlobeNewsWire
- 4 months ago - Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024 - GlobeNewsWire